Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-31,600
Closed -$2.53M 17
2019
Q2
$2.53M Sell
31,600
-38,529
-55% -$2.95M 3.62% 4
2019
Q1
$5.57M Sell
70,129
-9,458
-12% -$707K 5.05% 1
2018
Q4
$5.8M Sell
79,587
-21,333
-21% -$1.51M 4.86% 1
2018
Q3
$6.83M Sell
100,920
-6,451
-6% -$411K 3.91% 4
2018
Q2
$6.22M Buy
+107,371
New +$6.06M 3.36% 12
2017
Q2
Sell
-286,343
Closed -$17.4M 35
2017
Q1
$17.4M Sell
286,343
-10,909
-4% -$662K 3.78% 8
2016
Q4
$16.7M Buy
297,252
+33,137
+13% +$1.94M 3.47% 15
2016
Q3
$15.7M Buy
264,115
+25,202
+11% +$1.47M 3.58% 9
2016
Q2
$13.1M Buy
238,913
+68,300
+40% +$3.63M 3.47% 13
2016
Q1
$8.61M Buy
170,613
+40,007
+31% +$1.96M 2.99% 21
2015
Q4
$6.58M Buy
+130,606
New +$6.58M 3.16% 18

Other funds holding MRK

SkyBridge Capital II's MRK Position: Q3 2019 in Review

SkyBridge Capital II sold out of Merck (MRK) in Q3 2019, closing a stake of 31,600 shares — an estimated $2.53M sold.

SkyBridge Capital II first reported a position in MRK in Q4 2015 and held it in 11 quarters. The position peaked at $17.4M in Q1 2017. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • SkyBridge Capital II reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • SkyBridge Capital II sold 31,600 Merck shares in Q3 2019, an estimated $2.53M.
  • SkyBridge Capital II first reported a position in Merck in Q4 2015 and held it in 11 quarters.
  • SkyBridge Capital II's Merck position peaked at $17.4M in Q1 2017.
  • 2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on SkyBridge Capital II's 13F filing for Q3 2019.